MMRGlobal Shareholder Update on Walgreens Litigation
December 02 2013 - 8:15AM
Marketwired
MMRGlobal Shareholder Update on Walgreens Litigation
LOS ANGELES, CA--(Marketwired - Dec 2, 2013) - MyMedicalRecords,
Inc., through its wholly owned subsidiary, MMRGlobal, Inc. (OTCQB:
MMRF) (collectively, "MMR"), today announced that Walgreen Co.
filed a Joint Stipulation requesting additional time to respond to
a motion brought by MyMedicalRecords. The November 26, 2013 filing
states, amongst other things, that during the week of November 11,
2013 and prior to filing MMR's motion, the parties engaged in
various telephone conversations regarding a resolution to MMR's
patent infringement case against Walgreen Co. filed in the United
States District Court, Central District Case No.: CV13-00631-ODW
(SHx). Ultimately the parties agreed to an in-person meeting at
Walgreen Co. in Deerfield, IL on Tuesday, November 19, which
meeting did occur.
The parties continued to exchange e-mails regarding a resolution
to the litigation after the November 19th in-person meeting and
continue to discuss a resolution of the matter notwithstanding the
pending motion.
As set forth in the stipulation, another follow-up meeting is
currently scheduled for December 3, 2013. The parties desire to
focus on a potential resolution over the next week and a half
instead of incurring costs and attorneys' fees associated with this
matter.
Based upon the joint resolution, the court granted the
stipulation.
About MMRGlobal MMRGlobal, Inc., through its wholly-owned
operating subsidiary, MyMedicalRecords, Inc., provides secure and
easy-to-use online Personal Health Records ("PHRs") and electronic
safe deposit box storage solutions, serving consumers, healthcare
professionals, employers, insurance companies, financial
institutions, retail pharmacies, and professional organizations and
affinity groups. The MyMedicalRecords PHR enables individuals and
families to access their medical records and other important
documents, such as birth certificates, passports, insurance
policies and wills, anytime from anywhere using the Internet.
MyMedicalRecords is built on proprietary, patented technologies to
allow documents, images and voicemail messages to be transmitted
and stored in the system using a variety of methods, including fax,
phone, or file upload without relying on any specific electronic
medical record platform to populate a user's account. The Company's
professional offering, MMRPro, is designed to give physicians'
offices an easy and cost-effective solution to digitizing
paper-based medical records and sharing them with patients through
an integrated patient portal. Through its merger with Favrille,
Inc. in January 2009, the Company acquired intellectual property
biotech assets that include anti-CD20 antibodies and data and
samples from its FavId™/Specifid™ vaccine clinical trials for the
treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about
MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video
tutorials of the Company's products and services at
www.mmrtheater.com.
Forward-Looking Statements All statements in this press release
that are not strictly historical in nature, including, without
limitation, intellectual property enforcement actions, infringement
claims or litigation, intellectual property licenses, and future
performance, management's expectations, beliefs, intentions,
estimates or projections, constitute "forward-looking statements."
Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause MMR's actual results
to be materially different from historical results or from any
results expressed or implied by such forward-looking statements.
Some can be identified by the use of words (and their derivations)
such as "need," "possibility," "potential," "intend," "offer,"
"development," "if," "negotiate," "when," "begun," "believe,"
"achieve," "will," "estimate," "expect," "maintain," "plan," and
"continue," or the negative of these words. Actual outcomes and
results of operations and the timing of selected events may differ
materially from the results predicted, and any reported results
should not be considered as an indication of future performance.
Such statements are necessarily based on assumptions and estimates
and are subject to various risks and uncertainties, including those
relating to the possible invalidity of the underlying assumptions
and estimates and possible changes or developments in economic,
business, industry, market, legal and regulatory circumstances and
conditions and actions taken or omitted to be taken by third
parties, including customers, suppliers, business partners,
potential licensees, competitors and legislative, judicial and
other governmental authorities and officials. Factors that could
cause or contribute to such differences include, but are not
limited to: unexpected outcomes with respect to intellectual
property enforcement actions, claims of intellectual property
infringement and general intellectual property litigation; our
ability to maintain, develop, monetize and protect our patent
portfolio for both MMR's health IT and biotechnology intellectual
property assets in the U.S. and internationally; the timing of
milestone payments in connection with licensing our intellectual
property; our ability to establish and maintain strategic
relationships; changes in our relationships with our licensees; the
risk MMR's products are not adopted or viewed favorably by the
healthcare community and consumer retail market; business
prospects, results of operations or financial condition; risks
related to the current uncertainty and instability in financial and
lending markets, including global economic uncertainties; the
timing and volume of sales and installations; the length of sales
cycles and the installation process; the market's acceptance of new
product and service introductions; competitive product offerings
and promotions; changes in government laws and regulations
including the 2009 HITECH Act and changes in Meaningful Use and the
2010 Affordable Care Act; future changes in tax legislation and
initiatives in the healthcare industry; undetected errors in our
products; the possibility of interruption at our data centers;
risks related to third party vendors; risks related to obtaining
and integrating third-party licensed technology; risks related to a
security breach by third parties; risks associated with recruitment
and retention of key personnel; other litigation matters;
uncertainties associated with doing business internationally across
borders and territories; and additional risks discussed in MMR's
filings with the Securities and Exchange Commission. MMR is
providing this information as of the date of this release and,
except as required by applicable law, does not undertake any
obligation to update any forward-looking statements contained in
this release as a result of new information, future events or
otherwise.
CONTACT: Michael Selsman Public Communications Co.
ms@publiccommunications.biz (310)
922-7033